Suspected Acute Limb Ischemia
Sudden decrease in limb perfusion threatening viability
Acute Limb Ischemia Management (ESVS 2020): Suspected Acute Limb Ischemia → Immediate Clinical Assessment → Immediate Anticoagulation → Rutherford Class...
Pathway Overview
18 steps
18 total
Sudden decrease in limb perfusion threatening viability
The 6 Ps of Acute Limb Ischemia
UFH unless contraindicated
Determines treatment urgency
No sensory or motor deficit
Embolic vs Thrombotic
First-line for embolic ALI
Critical monitoring period
Address underlying cause
Successful revascularization - 75-90% for Class I-IIa, lower for IIb
10-30% overall; 100% for Class III; consider quality of life
CDT or mechanical thrombectomy
For thrombosis with extensive disease
Minimal sensory loss (toes)
Rest pain, sensory loss beyond toes, mild-moderate motor deficit
Profound sensory and motor loss, muscle rigor
For irreversible ischemia (Class III)
CTA preferred - do not delay treatment
ESVS 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Applicable Regions
EU: ESVS 2020 is current standard of care
US: SVS guidelines align with ESVS principles
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
The Acute Limb Ischemia Management (ESVS 2020) is a emergency clinical algorithm for Vascular Surgery. It provides a structured decision tree to guide clinical decision-making, based on ESVS 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia.
This algorithm is based on ESVS 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia (DOI: 10.1016/j.ejvs.2019.09.006).
Known limitations include: Time-critical emergency - revascularization within 6 hours optimal for IIb; Requires immediate vascular surgery consultation; CTA may delay treatment in obvious cases - clinical assessment paramount; Compartment syndrome monitoring essential post-revascularization; Does not cover blue toe syndrome or microembolization in detail. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the Acute Limb Ischemia Management (ESVS 2020) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free